ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
68.035,26
0,46%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Anthera Pharmaceuticals Inc (CE) (ANTH)

  7. Anthera Pharmaceuticals Inc (CE) (ANTH) News

ANTH

Anthera Pharmaceuticals (CE) (ANTH)

Anthera Pharmaceuticals Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ANTH
DatumZeitQuelleÜberschriftSymbolFirma
12/09/201821h21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
30/07/201822h45Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201812h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201812h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201812h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201812h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201812h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201812h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/07/201812h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h28Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h28Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h28Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h23Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h22Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h21Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
20/07/201822h06Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
17/07/201820h38Edgar (US Regulatory)(25)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
09/07/201823h08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/06/201822h14Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
27/06/201814h00GlobeNewswire Inc.Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the...USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
18/06/201822h32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ANTHAnthera Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ANTH

Kürzlich von Ihnen besucht

DBI
DAX
DAX
CCOM
SILVER
SILVER
CCOM
US30
US 30
NYSE
NKE
Nike
TG
D7G
Nel ASA
USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
NASDAQ
AMZN
Amazon.com
TG
RHM
Rheinmetall
FX
EURGBP
Euro vs Sterling
NYSE
DIS
Walt Disney
CCOM
US100
US Tech 100
TG
BAS
BASF
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten